Novavax, Inc. (NVAX) Covered Calls

Novavax, Inc. covered calls Novavax, a clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

You can sell covered calls on Novavax, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NVAX (prices last updated Thu 4:16 PM ET):

Novavax, Inc. (NVAX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.53 -0.05 5.54 5.55 5.2M - 0.7
Covered Calls For Novavax, Inc. (NVAX)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Dec 15 5.5 0.30 5.25 4.8% 195%
Jan 19 5 0.86 4.69 6.6% 54.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Novavax, Inc. operates as a clinical-stage biopharmaceutical company, which engages in development of novel recombinant vaccines to address a broad range of infectious diseases. The company's technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles and recombinant nanoparticle vaccines. Its product pipeline targets a variety of infectious diseases and currently has completed clinical trials that target pandemic influenza (H5N1), seasonal influenza and Respiratory Syncytial Virus. Novavax was founded in 1987 and is headquartered in Gaithersburg, MD.